NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Thu, 9 Jul · 19:09 IST

42nd AGM notice on August 4, 2026; final dividend of Rs 34 per share

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹19563.00
prior close
₹19701.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.9-0.7-0.4-3.0-2.9-2.3-3.9-5.8-3.4
Up moveDown movePending
AI summary

Neuland Laboratories has notified the 42nd AGM on August 4, 2026 at 10:00 AM via video conferencing. Items include adoption of audited FY2025-26 financials, final dividend of Rs 34 per share (340% on face value Rs 10), re-appointment of Dr. Davuluri Rama Mohan Rao, commission to Non-Executive Directors (up to 1% of net profits for 5 years), appointment of Dr. Mauricio Futran as Non-Executive Non-Independent Director, his professional fees, and ratification of Cost Auditors fee of Rs 4 lakh. Record date: July 24, 2026.

Likely market impact

Routine AGM notice with final dividend of Rs 34 per share for FY26. Director changes and commission approval are standard governance matters.